HTG Molecular Diagnostics stock analysis
HTG Molecular Diagnostics (HTGMQ) Stock Price & Analysis
HTGMQ Stock Chart & Stats
- Day’s Range
- $0.01 - $0.02
- 52-Week Range
- $0.00 - $0.45
- Previous Close
- $0.34
- Volume
- N/A
- Average Volume (3M)
- 5,708
- Market Cap
- $2
- Enterprise Value
- $7.21M
- Total Cash (Recent Filing)
- $6.56M
- Total Debt (Recent Filing)
- $3.98M
- Price to Earnings (P/E)
- 0.0
- Beta
- -273.75
- Next Earnings
- N/A
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
HTGMQ FAQ
What was HTG Molecular Diagnostics’s price range in the past 12 months?
What is HTG Molecular Diagnostics’s market cap?
When is HTG Molecular Diagnostics’s upcoming earnings report date?
How were HTG Molecular Diagnostics’s earnings last quarter?
Is HTG Molecular Diagnostics overvalued?
Does HTG Molecular Diagnostics pay dividends?
What is HTG Molecular Diagnostics’s EPS estimate?
How many shares outstanding does HTG Molecular Diagnostics have?
What happened to HTG Molecular Diagnostics’s price movement after its last earnings report?
Which hedge fund is a major shareholder of HTG Molecular Diagnostics?
What is the TipRanks Smart Score and how is it calculated?
Company Description
HTG Molecular Diagnostics
HTG Molecular Diagnostics, Inc. operates as a life sciences company, specializing in the realm of precision medicine. They furnish specialized instruments, consumable products, and software applications engineered to automate the processing of samples and characterize a variety of molecular targets. Among their portfolio of molecular profiling panels are offerings like the HTG Transcriptome Panel, HTG EdgeSeq precision immuno-oncology panel, HTG EdgeSeq miRNA whole-transcriptome assay, HTG EdgeSeq DLBCL cell of origin assay EU, HTG EdgeSeq Oncology Biomarker Panel, HTG immune response panel, and the HTG mouse mRNA tumor response panel. The company handles direct distribution of its instruments and consumables across the United States and Europe, supplementing this with a network of distributors for other parts of Europe and global markets. Its customer base primarily includes biopharmaceutical corporations, academic research institutions, and molecular testing laboratories. Incorporated in 1997 and based in Tucson, Arizona, the entity was formerly known as HTG, Inc., adopting its current name, HTG Molecular Diagnostics, Inc., in March 2011. However, on June 5, 2023, HTG Molecular Diagnostics, Inc. initiated a voluntary Chapter 11 reorganization filing with the U.S. Bankruptcy Court for the District of Delaware.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- John L. Lubniewski
- Employees
- 53
- Website
- www.htgmolecular.com
- Address
- 3430 East Global Loop, Tucson, AZ, 85706, US

